2021 Archives
You are viewing archived information from 2021
SR172 SD1     
Measure Title: REQUESTING THE DEPARTMENT OF HEALTH TO CONVENE A MEDICINAL PSILOCYBIN AND PSILOCIN WORKING GROUP TO EXAMINE THE MEDICINAL AND THERAPEUTIC EFFECTS OF PSILOCYBIN AND PSILOCIN OR DEVELOP A LONG-TERM STRATEGIC PLAN TO ENSURE THE AVAILABILITY OF MEDICINAL PSILOCYBIN AND PSILOCIN OR PSILOCYBIN-BASED AND PSILOCIN-BASED PRODUCTS THAT ARE SAFE, ACCESSIBLE, AND AFFORDABLE FOR ELIGIBLE ADULT PATIENTS.
Report Title: Medicinal Psilocybin and Psilocin Working Group; Department of Health
Description:
Companion:  SCR208
Package: None
Current Referral: HTH
Introducer(s): CHANG, GABBARD, LEE, Wakai
Act:

Sort by Date Status Text
6/21/2021SCertified copies of resolutions sent, 06-21-21.
3/31/2021SReport and Resolution Adopted as amended (SD 1). Aye(s) with reservations: Senator(s) Fevella. Noes, 0 (none).
3/30/2021SOne Day Notice 03-31-21.
3/30/2021SReported from HTH (Stand. Com. Rep. No. 1408) with recommendation of adoption, as amended (SD 1).
3/29/2021SThe committee(s) on HTH recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HTH were as follows: 5 Aye(s): Senator(s) Keohokalole, Baker, Moriwaki, San Buenaventura; Aye(s) with reservations: Senator(s) Fevella ; 0 No(es): none; and 0 Excused: none.
3/25/2021SThe committee(s) on HTH has scheduled a public hearing on 03-29-21 1:20PM; Via Videoconference.
3/16/2021SReferred to HTH.
3/12/2021SOffered.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


SR172 SD1
All Versions of this Measure

Committee Reports

Testimony
No testimony available at this time.

Hearing Notices
HTH
3/29/21 1:20P
Via Videoconference